The heart disease drug, which 29-year-old Sharapova says she has been taking following 2006 for wellbeing issues, turned into a banned substance on 1 January 2016.
Sharapova will challenge the suspension, which is predated to 26 January 2016, at the Court of Arbitration for Sport (Cas). The five-time Grand Slam champ said she "cannot accept" the "unfairly harsh" ban - and will appeal.
In an announcement, she said the tribunal closed her offense was "unintentional" and that she had not attempted to utilize a "performance-enhancing substance".
Be that as it may, she asserted the ITF had approached the tribunal for a four-year ban, claiming it invested gigantic measures of energy and assets attempting to demonstrate I deliberately abused the counter doping rules.
The tribunal ruling said Sharapova tested positive for meldonium in an out-of competition test on 2 February, and also in the outcome of her Australian Open quarter-last defeat by Serena Williams on 26 January. It regarded both results as a single anti-doping violation.
The London 2012 Olympic silver medallist included: "I have missed playing tennis and I have missed my amazing fans... your love and support has gotten me through these tough days. "I intend to stand for what I believe is right and that's why I will fight to be back on the tennis court as soon as possible."
Sharapova had as of now conceded she kept taking the substance past that date, saying she was unconscious it had been added to the banned rundown as she knew it by another name - mildronate.
No comments:
Post a Comment